FDA Approval of Pfizer-BioNTech COVID-19 Vaccine - Frequently Asked Questions'
September 22, 2021
September 22, 2021
WASHINGTON, Sept. 22 (TNSRep) -- The Congressional Research Service issued the following report (No. R46913) on Sept. 17, 2021, entitled "FDA Approval of the Pfizer-BioNTech COVID-19 Vaccine: Frequently Asked Questions" by legislative attorneys Kevin J. Hickey and Erin H. Ward and health policy analyst Agata Bodie:
* * *
SUMMARY
On August 23, 2021, the U.S. Food and Drug Administration (FDA) announced its regulatory approval of the Pfizer-BioNTech . . .
* * *
SUMMARY
On August 23, 2021, the U.S. Food and Drug Administration (FDA) announced its regulatory approval of the Pfizer-BioNTech . . .